Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment

Raymond Miralbell(University of Geneva), Alain Keller(University Hospital of Geneva), Sabine Bieri(University Hospital of Geneva), Gemma Sancho(Hospital de Sant Pau), Ignasi Carrió(Hospital de Sant Pau), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Claudine Helg(University Hospital of Geneva), B Chapuis(University Hospital of Geneva), Pierre‐Yves Martin(University Hospital of Geneva), G. Gómez de Segura(Hospital de Sant Pau), Montserrat Estorch(Hospital de Sant Pau), Mahmut Özsahin(Centre Hospitalier Universitaire Vaudois), Salut Brunet(Institut Català d'Oncologia)
International Journal of Radiation Oncology*Biology*Physics
February 10, 2004
10.1016/j.ijrobp.2003.06.001
Cited by 67

Related Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2015|740
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
|The Lancet Oncology|2014|679
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538